Kevin Escandón-Vargas
-
- Antibiotic Use and Resistance 6
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 3
- Endocrinology top 5%
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies 3
- Clinical Biochemistry top 10%
-
- Airway Management and Intubation Techniques 4
-
- Nosocomial Infections in ICU 3
-
- Surgical site infection prevention 3
-
- Pharmaceutical Economics and Policy 3
-
- Dermatological diseases and infestations 3
- Co-authors
- María Virginia VillegasAndrés Zorrilla‐VacaSergio ReyesSergio GutiérrezSaskia PopescuAngela L. RasmussenJason KindrachukIsaac I. Bogoch
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- ColombiaUnited StatesMexico
In The Last Decade
Kevin Escandón-Vargas
32 papers receiving 710 citations
Peers
Comparison fields: 5 of 119
- Applied Microbiology and Biotechnology 171
- Molecular Medicine 234
- Endocrinology 96
- Modeling and Simulation 48
- Clinical Biochemistry 60
Countries citing papers authored by Kevin Escandón-Vargas
This map shows the geographic impact of Kevin Escandón-Vargas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Escandón-Vargas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Escandón-Vargas more than expected).
Fields of papers citing papers by Kevin Escandón-Vargas
This network shows the impact of papers produced by Kevin Escandón-Vargas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Escandón-Vargas. The network helps show where Kevin Escandón-Vargas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin Escandón-Vargas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2022 | 15 | |
| 3 | 2021 | 109 | |
| 4 | 2021 | 24 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 23 | |
| 7 | Opportunistic intestinal parasites in immunocompromised patients from a tertiary hospital in Monterrey, Mexico. | 2019 | 14 |
| 8 | 2018 | 3 | |
| 9 | 2018 | 6 | |
| 10 | 2017 | 4 | |
| 11 | 2017 | 31 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 5 | |
| 14 | 2016 | 37 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 162 | |
| 17 | 2016 | 68 | |
| 18 | Risk of urinary tract infection in patients with positive urine culture and antibiotic therapy undergoing cystoscopy in a third-level hospital. | 2015 | 2 |
| 19 | 2015 | 7 | |
| 20 | 2015 | 50 |
About Kevin Escandón-Vargas
Kevin Escandón-Vargas is a scholar working on Applied Microbiology and Biotechnology, Parasitology and Anesthesiology and Pain Medicine, having authored 33 papers that have together received 726 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Airway Management and Intubation Techniques (4 papers), COVID-19 epidemiological studies (3 papers), Antibiotic Resistance in Bacteria (3 papers), Nosocomial Infections in ICU (3 papers), Surgical site infection prevention (3 papers), Pharmaceutical Economics and Policy (3 papers) and Dermatological diseases and infestations (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (171 citations), Molecular Medicine (234 citations) and Endocrinology (96 citations). Kevin Escandón-Vargas has collaborated with scholars based in Colombia, United States and Mexico. Frequent co-authors include María Virginia Villegas, Andrés Zorrilla‐Vaca, Sergio Reyes, Sergio Gutiérrez, Saskia Popescu, Angela L. Rasmussen, Jason Kindrachuk, Isaac I. Bogoch, Eleanor J. Murray and Adrian Brink. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.